The U.S. Intra cranial pressure monitoring devices market is segmented into two type extra ventricular drainage devices (EVD) and Intra cranial pressure (ICP) monitors. Further the EVD devices is further segmented into catheters, microtransducers, subarchnoid screws, air pouch devices. Microtranduscrs used in EVD devices constitute of following devices fiber optic devices, microchips and others. ICP devices have usage in multiple applications such as traumatic brain injury (TBI), intracerebral hemorrhage, meningitis among others. This report provides you with market value of ICP devices segmented by the aforementioned applications.
The U.S. ICP monitoring devices market is accounted to be USD 90.0 million in 2014 expected to reach USD 120.1 million by 2020, growing at a CAGR of 4.7% in the forecasted period 2015 to 2020. The U.S. market holds 44.5% market share of the global ICP monitoring devices market. The EVD devices segment dominates this market with 81.1% share in 2014, having the market value of USD 72.9 million. While in EVD devices market catheters and microtransducers holds a combination share of 71.7% in this market in 2014, accounting to USD 51.8 million together. Based on application, TBI is the major cause for usage of ICP monitoring devices in U.S., 42.% of the usage of these devices is owing to TBI.
In 2014, 2.9 million TBI is recorded in U.S. according to Center of Disease Control (CDC) which is expected to reach 3.3 million TBI by 2020, growing at a CAGR of 2.7% in the forecasted period of 2015 to 2020. Another major application of these devices is in intracerebral hemorrhage, according to Matthew L. Flaherty, Daniel Woo, and Joseph P. Broderick it accounts for 12 – 15% of all strokes in Western populations and is well-defined as the non-traumatic, sudden onset of severe headache, rehabilitated level of consciousness, or focal neurological insufficiency associated with a focal collection of blood within the brain parenchyma on neuroimaging or at autopsy which is not due to trauma or hemorrhagic conversion of a cerebral infarction. Growing awareness of neurological degenerative diseases, such as autism, dyslexia, epilepsy, hydrocephalus, alexander disease among others has resulted in decreased morbidity and mortality, which is expected to bolster the demand for ICP monitoring devices in U.S.
There a very few major players operating in this market, and is mostly dominated by a single company but the scenario is expected to alter in near future with many new entrants expected to enter this market soon. Integra LifeSciences Corporation, holds the majority of this market with 70.5% of the market, followed by Codman &Shurtleff, Inc. and Raumedic AG among others.